Literature DB >> 29694913

Effects of taurine on striatal dopamine transporter expression and dopamine uptake in SHR rats.

Vincent Chin-Hung Chen1, Chun-Ching Chiu2, Li-Jeng Chen3, Tsai-Ching Hsu4, Bor-Show Tzang5.   

Abstract

Dopaminergic deficits in the prefrontal cortex and striatum have been attributed to the pathogenesis of attention-deficit hyperactivity disorder (ADHD). Our recent study revealed that high-dose taurine improves hyperactive behavior and brain-functional signals in SHR rats. This study investigates the effect of taurine on the SHR striatum by detecting the spontaneous alternation, DA transporter (DAT) level, dopamine uptake and brain-derived neurotrophic factor (BDNF) expression. A significant increase in the total arm entries was detected in both WKY and SHR rats fed with low-dose taurine but not in those fed with high-dose taurine. Notably, significantly increased spontaneous alternation was observed in SHR rats fed with high-dose taurine. Significantly higher striatal DAT level was detected in WKY rats fed with low-dose taurine but not in SHR rats, whereas significantly reduced striatal DAT level was detected in SHR rats fed with high-dose taurine but not in WKY rats. Significantly increased dopamine uptake was detected in the striatal synaptosomes of both WKY and SHR rats fed with low-dose taurine. Conversely, significantly reduced dopamine uptake was detected in the striatal synaptosomes of SHR rats fed with high-dose taurine. Accordingly, a negative correlation was detected between striatal dopamine uptake and spontaneous alternation in SHR rats fed with low or high-dose taurine. Significantly increased BDNF was detected in the striatum of both WKY and SHR rats fed with low or high-dose taurine. These findings indicate that different dosages of taurine have opposite effects on striatal DAT expression and dopamine uptake, suggesting high-dose taurine as a possible candidate for ADHD treatment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention-deficit hyperactivity disorder (ADHD); DA transporter (DAT); Dopamine; Taurine

Mesh:

Substances:

Year:  2018        PMID: 29694913     DOI: 10.1016/j.bbr.2018.04.031

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  4 in total

1.  Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women.

Authors:  Matheus Uba Chupel; Luciele Guerra Minuzzi; Guilherme Eustáquio Furtado; Mário Leonardo Santos; José Pedro Ferreira; Edith Filaire; Ana Maria Teixeira
Journal:  Amino Acids       Date:  2021-02-13       Impact factor: 3.520

Review 2.  Calixarenes: Generalities and Their Role in Improving the Solubility, Biocompatibility, Stability, Bioavailability, Detection, and Transport of Biomolecules.

Authors:  Edilma Sanabria Español; Mauricio Maldonado Villamil
Journal:  Biomolecules       Date:  2019-03-05

Review 3.  Improving Age-Related Cognitive Decline through Dietary Interventions Targeting Mitochondrial Dysfunction.

Authors:  Aleksandra Kaliszewska; Joseph Allison; Matteo Martini; Natalia Arias
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

4.  Taurine Protects against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine.

Authors:  Song-I Seol; Hyun Jae Kim; Eun Bi Choi; In Soon Kang; Hye-Kyung Lee; Ja-Kyeong Lee; Chaekyun Kim
Journal:  Antioxidants (Basel)       Date:  2021-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.